Dr. Joaquin Dopazo is the director of the Platform of Computational Medicine of the Progress and Health Foundation from the Andalusian Health System. He has a degree in Chemistry and a PhD in Biology (University of Valencia, 1989). He has lead bioinformatics and data science departments in different academic institutions (CIPF in Valencia and CNIO in Madrid) and companies (Glaxo Wellcome, Madrid, Spain). Dr. Dopazo’s interests revolve around functional genomics, systems biology as well as development of new algorithms and software for the analysis of high-throughput genomic data and electronical health record data and its application to personalized and precision medicine and drug discovery, making intensive use of mathematical modeling and artificial intelligence. He has published more than 350 papers in international peer-reviewed journals, reaching an h-index of 70. He has promoted genomic initiatives such as the Medical Genome Project, and has participated in numerous national and international initiatives and consortia (e.g. IMPaCT-data, MAQC, ELIXIR, 1+Million genomes etc.)